Berdel AF, Koch R, Gerss J, Hentrich M, et al. A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy. Ann Hematol 2022 Nov 18. pii: 10.1007/s00277-022-05025.
PMID: 36399194